Please assess the completion status of the following clinical trial:

Trial Title: Concentration of Ertapenem in Colorectal Tissue

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Hospitalized patients 18 years or older requiring elective surgical intervention (open or laparoscopic surgery) at the colon will be eligible for this study.~* Patients with benignant disorders (e.g. colonic diverticulosis) will be preferred.~Exclusion Criteria:~* Pregnancy or lactation in women~* Emergency surgery, history of serious allergy or intolerance to β-lactam antibiotics and other carbapenems~* Systemic antimicrobial therapy with ceftazidime (internal standard of high-performance liquid chromatography / mass spectrometry) within a 7 days period prior to study entry~* Ongoing intraabdominal infections~* Terminal illness~* Chronic immunosuppressive therapy~* Severe diseases of the liver, e.g. cirrhosis of the liver with ALT or AST \> 6 x upper limit of normal (ULN) and bilirubin \> 3 x ULN, severe renal insufficiency with a creatinine clearance ≤30 mL/min., neutrophil count \< 1000 cells/mm3, platelets \< 75000 cells/mm3 and coagulation studies (INR) \> 1.5 x ULN, ongoing therapy with valproin acid.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Ertapenem (Type: EXPERIMENTAL): Administration of 1 gram ertapenem I.V.

Based on this trial design, predict the completion outcome and termination type (if applicable).